Page last updated: 2024-10-31

entinostat and Pancreatitis, Chronic

entinostat has been researched along with Pancreatitis, Chronic in 1 studies

Pancreatitis, Chronic: INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.

Research Excerpts

ExcerptRelevanceReference
"Pancreatitis is a common inflammation of the pancreas with rising incidence in many countries."1.46Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia. ( Bombardo, M; Chen, R; Graf, R; Haumaitre, C; Malagola, E; Quilichini, E; Reding, T; Saponara, E; Seleznik, GM; Sonda, S; Zabel, A, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bombardo, M1
Saponara, E1
Malagola, E1
Chen, R1
Seleznik, GM1
Haumaitre, C1
Quilichini, E1
Zabel, A1
Reding, T1
Graf, R1
Sonda, S1

Other Studies

1 other study available for entinostat and Pancreatitis, Chronic

ArticleYear
Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia.
    British journal of pharmacology, 2017, Volume: 174, Issue:21

    Topics: Acinar Cells; Acute Disease; Animals; Autoimmune Diseases; Benzamides; Disease Models, Animal; ErbB

2017